Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,069 public trials 582 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Recruiting

A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma

NCT06669247

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Royal Prince Alfred Hospital Sydney, New South Wales, Australia
  • Illawarra Cancer Care Centre Wollongong, New South Wales, Australia
  • Pindara Private Hospital Benowa, Queensland, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
View Trial Details
Recruiting

68Ga-BCMA PET/CT in Multiple Myeloma

NCT07319897

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease, +17 more
Locations
  • Beijing An Zhen Hospital of the Capital University of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Tsinghua Changgung Hospital Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • the Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
View Trial Details
Recruiting

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

NCT04566328

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 649 locations
View Trial Details
Recruiting

A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

NCT07231952

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Dana Farber Cancer Institute (Data Collection and Specimen Analysis) Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memoral Sloan Kettering Monmouth Middletown, New Jersey, United States
View Trial Details
Recruiting

A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma

NCT07454382

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All Protocol Activities) Commack, New York, United States
View Trial Details

Related conditions